Literature DB >> 11960572

Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high-performance liquid chromatography.

G Wu1, W Wu, M Hegde, M Fawkner, B Chong, D Love, L K Su, P Lynch, K Snow, C S Richards.   

Abstract

We have evaluated the usefulness of denaturing high performance liquid chromatography (dHPLC) for scanning the adenomatous polyposis coli (APC) gene for point mutations, small deletions, and insertions. Our assay consists of 28 sets of primers to amplify the 15 exons of the APC gene. All PCR reactions were amplified simultaneously using the same reaction conditions in a 96-well format and then analyzed by dHPLC, using empirically determined optimum temperatures for partial fragment denaturation. Previously studied DNA specimens from 47 familial adenomatous polyposis (FAP) patients were analyzed by dHPLC and all mutations were correctly identified and confirmed by sequence analysis. This approach identified a single-base substitution in exon 6 and a 2-bp insertion in exon 15 that initially had not been detected by single-strand conformational polymorphism (SSCP) analysis. A novel mutation in exon 15 of the APC gene, 2065delG (codon 689) that had previously been undetected by the protein truncation test (PTT) was also identified by dHPLC. We present our validation studies of dHPLC technology for APC gene analysis in terms of sensitivity and specificity and compare it to current standard scanning technologies including PTT, SSCP, and conformational sensitive gel electrophoresis (CSGE).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11960572     DOI: 10.1089/109065701753617408

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  8 in total

1.  Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.

Authors:  Celia S Chen; Kerry D Phillips; Scott Grist; Graeme Bennet; Jamie E Craig; James S Muecke; Graeme K Suthers
Journal:  Fam Cancer       Date:  2006-08-31       Impact factor: 2.375

2.  Targeting tumor suppressor networks for cancer therapeutics.

Authors:  Xuning Emily Guo; Bryan Ngo; Aram Sandaldjian Modrek; Wen-Hwa Lee
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

3.  Increased variance in germline allele-specific expression of APC associates with colorectal cancer.

Authors:  Maria Cristina Curia; Sabrina De Iure; Laura De Lellis; Serena Veschi; Sandra Mammarella; Marquitta J White; Jacquelaine Bartlett; Angelo Di Iorio; Cristina Amatetti; Marco Lombardo; Patrizia Di Gregorio; Pasquale Battista; Renato Mariani-Costantini; Scott M Williams; Alessandro Cama
Journal:  Gastroenterology       Date:  2011-10-10       Impact factor: 22.682

4.  Assay validation for identification of hereditary nonpolyposis colon cancer-causing mutations in mismatch repair genes MLH1, MSH2, and MSH6.

Authors:  Madhuri Hegde; Maria Blazo; Belinda Chong; Tom Prior; Carolyn Richards
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

5.  APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations.

Authors:  Per Arne Andresen; Ketil Heimdal; Kristin Aaberg; Katrine Eklo; Kristin Eklo; Sarah Ariansen; Alexandra Silye; Olav Fausa; Lars Aabakken; Stefan Aretz; Tor J Eide; Tobias Gedde-Dahl
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-15       Impact factor: 4.553

6.  Deep sequencing with intronic capture enables identification of an APC exon 10 inversion in a patient with polyposis.

Authors:  Brian H Shirts; Stephen J Salipante; Silvia Casadei; Shawnia Ryan; Judith Martin; Angela Jacobson; Tatyana Vlaskin; Karen Koehler; Robert J Livingston; Mary-Claire King; Tom Walsh; Colin C Pritchard
Journal:  Genet Med       Date:  2014-03-27       Impact factor: 8.822

7.  Precancerous lesions in colorectal cancer.

Authors:  Fayez Sandouk; Feras Al Jerf; M H D Bassel Al-Halabi
Journal:  Gastroenterol Res Pract       Date:  2013-05-14       Impact factor: 2.260

8.  Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.

Authors:  Janos Papp; Marietta Eva Kovacs; Zoltan Matrai; Enikő Orosz; Miklós Kásler; Anne-Lise Børresen-Dale; Edith Olah
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.